Comparative proteomic analysis reveals differentially expressed proteins regulated by a potential tumor promoter, BRE, in human esophageal carcinoma cells

Biochemistry and Cell Biology

Volumn 86, Issue 4, 2008, Pages 302-311

  Chen, Hai Bin ^a,b   Pan, Ke ^a   Tang, Mei Kuen ^c,d   Chui, Yiu Loon ^e   Chen, Ling ^a   Su, Zhong Jing ^a   Shen, Zhong Ying ^b   Li, En Min ^a   Xie, Wei ^f   Lee, Kenneth K H ^c,d  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b Guangdong Key Laboratory of Medical Molecular Imaging   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d Laboratory for Regenerative Medicine

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

BRE gene; Comparative proteomics; Esophageal carcinoma; siRNA; Tumor associated proteins

Indexed keywords

CELL PROLIFERATION; CELLS; CHLORINE COMPOUNDS; CYTOLOGY; ELECTROPHORESIS; NUCLEIC ACIDS; RNA; TUMORS; TWO DIMENSIONAL;

ANTIAPOPTOTIC; BRE GENE; COMPARATIVE PROTEOMICS; CONTROL CELLS; CYCLIN A; ESOPHAGEAL CARCINOMA; IMMUNOBLOTTING; MALDI-TOF-MS; PROHIBITIN; PROTEOMIC ANALYSIS; PROTEOMIC APPROACHES; SIRNA; SMALL INTERFERENCE RNA; TUMOR-ASSOCIATED PROTEINS; TUMORIGENESIS; TWO-DIMENSIONAL ELECTROPHORESIS;

PROTEINS;

BETA TUBULIN; BRAIN AND REPRODUCTIVE ORGAN EXPRESSED PROTEIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; PROHIBITIN; PROTEIN P53; SMALL INTERFERING RNA; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR PROMOTION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NERVE TISSUE PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 49249104487     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O08-069     Document Type: Article

References (42)

1. Bani-Hani, K., Martin, I.G., Hardie, L.J., Mapstone, N., Briggs, J.A., Forman, D., and Wild, C.P. 2000. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J. Natl. Cancer Inst. 92: 1316-1321. doi:10.1093/jnci/92.16.1316. PMID:10944553.
2. Bindels, E.M., Lallemand, F., Balkenende, A., Verwoerd, D., and Michalides, R. 2002. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Oncogene, 21: 8158-8165. doi:10.1038/sj.onc.1206012. PMID:12444551.
3. Chan, B.C., Li, Q., Chow, S.K., Ching, A.K., Liew, C.T., Lim, P.L., et al. 2005. BRE enhances in vivo growth of tumor cells. Biochem. Biophys. Res. Commun. 326: 268-273. doi:10.1016/j.bbrc.2004.11.013. PMID:15582573.
4. Chan, B.C., Ching, A.K., To, K.F., Leung, J.C., Chen, S., Li, Q., et al. 2008. BRE is an anti-apoptotic protein in vivo and overexpressed in human hepatocellular carcinoma. Oncogene, 27: 1208-1217. doi:10.1038/sj.onc. 1210733. PMID:17704801.
5. Ching, A.K., Li, Q., Lim, P.L., Chan, J.Y., and Chui, Y.L. 2003. Expression of a conserved mouse stress-modulating gene, Bre: comparison with the human ortholog. DNA Cell Biol. 22: 497-504. doi:10.1089/ 10445490360708900. PMID:14565866.
6. Chowdhury, I., Xu, W., Stiles, J.K., Zeleznik, A., Yao, X., Matthews, R., et al. 2007. Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin. Endocrinology, 148: 206-217. doi:10.1210/en.2006-0187. PMID:17038561.
7. Daly, J.M., Karnell, L.H., and Menck, H.R. 1996. National cancer data base report on esophageal carcinoma. Cancer, 78: 1820-1828. doi:10.1002/(SICI)1097-0142(19961015) 78:8〈1820::AID-CNCR25〉3.0.CO;2- Z. PMID:8859198.
8. DeMeester, S.R., and DeMeester, T.R. 2000. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann. Surg. 231: 303-321. doi:10.1097/00000658-200003000-00003. PMID:10714623.
9. Dinjens, W.N. 2002. Genetic alterations in Barrett's esophagus and esophageal adenocarcinoma. Minerva Chir. 57: 733-752. PMID: 12592217.
10. Dobashi, Y., Shoji, M., Jiang, S.X., Kobayashi, M., Kawakubo, Y., and Kameya, T. 1998. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am. J. Pathol. 153: 963-972. PMID:9736045.
11. Dong, Y., Hakimi, M.A., Chen, X., Kumaraswamy, E., Cooch, N.S., Godwin, A.K., and Shiekhattar, R. 2003. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol. Cell, 12: 1087-1099. doi:10.1016/S1097-2765(03)00424-6. PMID:14636569.
12. Fusaro, G., Wang, S., and Chellappan, S. 2002. Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis. Oncogene, 21: 4539-4548. doi:10.1038/sj.onc.1205551. PMID:12085232.
13. Fusaro, G., Dasgupta, P., Rastogi, S., Joshi, B., and Chellappan, S. 2003. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 278: 47853-47861. doi:10.1074/jbc.M305171200. PMID: 14500729.
14. Gamble, S.C., Odontiadis, M., Waxman, J., Westbrook, J.A., Dunn, M.J., Wait, R., et al. 2004. Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene, 23: 2996-3004. doi:10.1038/sj.onc. 1207444. PMID:14968116.
15. Gu, C., Castellino, A., Chan, J.Y., and Chao, M.V. 1998. BRE: a modulator of TNF-α action. FASEB J. 12: 1101-1108. PMID: 9737713.
16. Koppert, L.B., Wijnhoven, B.P., van Dekken, H., Tilanus, H.W., and Dinjens, W.N. 2005. The molecular biology of esophageal adenocarcinoma. J. Surg. Oncol. 92: 169-190. doi:10.1002/jso.20359. PMID:16299787.
17. Kountouras, J., Boura, P., and Lygidakis, N.J. 2000. New concepts of molecular biology for colon carcinogenesis. Hepatogastroenterology, 47: 1291-1297. PMID:11100335.
18. Krek, W., Xu, G., and Livingston, D.M. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell, 83: 1149-1158. doi:10.1016/0092-8674(95)90141-8. PMID:8548802.
19. Kyrgidis, A., Kountouras, J., Zavos, C., and Chatzopoulos, D. 2005. New molecular concepts of Barrett's esophagus: clinical implications and biomarkers. J. Surg. Res. 125: 189-212. doi:10.1016/j.jss.2004.12.022. PMID:15854673.
20. Lehrbach, D.M., Nita, M.E., and Cecconello, I. 2003. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq. Gastroenterol. 40: 256-261. doi:10.1590/S0004-28032003000400011. PMID:15264049.
21. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331. doi:10.1016/S0092-8674(00)81871-1. PMID:9039259.
22. Li, L., Yoo, H., Becker, F.F., Ali-Osman, F., and Chan, J.Y. 1995. Identification of a brain- and reproductive-organs-specific gene responsive to DNA damage and retinoic acid. Biochem. Biophys. Res. Commun. 206: 764-774. doi:10.1006/bbrc.1995.1108. PMID:7826398.
23. Li, Q., Ching, A.K., Chan, B.C., Chow, S.K., Lim, P.L., Ho, T.C., et al. 2004. A death receptor-associated anti-apoptotic protein, BRE, inhibits mitochondrial apoptotic pathway. J. Biol. Chem. 279: 52106-52116. doi:10.1074/jbc.M408678200. PMID:15465831.
24. McManus, D.T., Olaru, A., and Meltzer, S.J. 2004. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res. 64: 1561-1569. doi:10.1158/0008-5472.CAN-03-2438. PMID:14996709.
25. Miao, J., Panesar, N.S., Chan, K.T., Lai, F.M., Xia, N., Wang, Y., et al. 2001. Differential expression of a stress-modulating gene, BRE, in the adrenal gland, in adrenal neoplasia, and in abnormal adrenal tissues. J. Histochem. Cytochem. 49: 491-500. PMID: 11259452.
26. Miao, J., Chan, K.W., Chen, G.G., Chun, S.Y., Xia, N.S., Chan, J.Y., and Panesar, N.S. 2005. Blocking BRE expression in Leydig cells inhibits steroidogenesis by down-regulating 3b-hydroxysteroid dehydrogenase. J. Endocrinol. 185: 507-517. doi:10.1677/joe.1.06079. PMID:15930177.
27. Nijtmans, L.G., Artal, S.M., Grivell, L.A., and Coates, P.J. 2002. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell. Mol. Life Sci. 59: 143-155. doi:10.1007/s00018-002-8411-0. PMID: 11852914.
28. Nishimori, T., Tomonaga, T., Matsushita, K., Oh-Ishi, M., Kodera, Y., Maeda, T., et al. 2006. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics, 6: 1011-1018. doi:10.1002/pmic.200500262. PMID:16400690.
29. Qi, Y., Chiu, J.F., Wang, L., Kwong, D.L., and He, Q.Y. 2005. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics, 5: 2960-2971. doi:10.1002/pmic.200401175. PMID:15986332.
30. Rastogi, S., Joshi, B., Dasgupta, P., Morris, M., Wright, K., and Chellappan, S. 2006. Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol. Cell. Biol. 26: 4161-4171. doi:10.1128/MCB.02142-05. PMID:16705168.
31. Reid, B.J., Prevo, L.J., Galipeau, P.C., Sanchez, C.A., Longton, G., Levine, D.S., et al. 2001. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am. J. Gastroenterol. 96: 2839-2848. doi:10.1111/j.1572-0241.2001. 04236.x. PMID:11693316.
32. Sato, T., Saito, H., Swensen, J., Olifant, A., Wood, C., Danner, D., et al. 1992. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res. 52: 1643-1646. PMID:1540973.
33. Shen, Z., Cen, S., Shen, J., Cai, W., Xu, J., Teng, Z., et al. 2000. Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J. Cancer Res. Clin. Oncol. 126: 589-594. doi:10.1007/PL00008469. PMID:11043396.
34. Shen, W.H., Yin, Y., Broussard, S.R., McCusker, R.H., Freund, G.G., Dantzer, R., and Kelley, K.W. 2004. Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J. Biol. Chem. 279: 7438-7446. doi:10.1074/jbc.M310264200. PMID:14681231.
35. Tang, M.K., Wang, C.M., Shan, S.W., Chui, Y.L., Ching, A.K., Chow, P.H., et al. 2006. Comparative proteomic analysis reveals a function of the novel death receptor-associated protein BRE in the regulation of prohibitin and p53 expression and proliferation. Proteomics, 6: 2376-2385. doi:10.1002/pmic.200500603. PMID: 16518872.
36. Wang, S., Nath, N., Adlam, M., and Chellappan, S. 1999a. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene, 18: 3501-3510. doi:10.1038/sj.onc.1202684. PMID:10376528.
37. Wang, S., Nath, N., Fusaro, G., and Chellappan, S. 1999b. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol. Cell. Biol. 19: 7447-7460. PMID:10523633.
38. White, K.A., Lange, E.M., Ray, A.M., Wojno, K.J., and Cooney, K.A. 2006. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q. Prostate Cancer Prostatic Dis. 9: 298-302. doi:10.1038/sj.pcan.4500878. PMID: 16733518.
39. Yam, C.H., Fung, T.K., and Poon, R.Y. 2002. Cyclin A in cell cycle control and cancer. Cell. Mol. Life Sci. 59: 1317-1326. doi:10.1007/s00018-002-8510-y. PMID:12363035.
40. Yamamoto, S., Kijima, H., Hara, T., Kenmochi, T., Kise, Y., Tanaka, H., et al. 2003. Immunohistochemical mucin expression of short-segment Barrett's esophagus. Tokai J. Exp. Clin. Med. 28: 57-63. PMID:14714830.
41. Zhou, Q., He, Q., and Liang, L.J. 2003. Expression of p27, cyclin E, and cyclin A in hepatocellular carcinoma and its clinical significance. World J. Gastroenterol. 9: 2450-2454. PMID: 14606074.
42. Zhou, G., Li, H., Gong, Y., Zhao, Y., Cheng, J., Lee, P., and Zhao, Y. 2005. Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. Proteomics, 5: 3814-3821. doi:10.1002/pmic.200401230. PMID: 16127732.